illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Pharmaessentia
Company logo

Pharmaessentia | Sustainability Performance

https://us.pharmaessentia.com

Produces biopharmaceutical products including treatments for metabolic and rare diseases.

2003

United States

501 - 1,000 employees

Biotechnology

$500M - 1B in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#5732
Overallⓘ
#1286
in United Statesⓘ
#131
in Biotechnologyⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

142 out of 243

Overview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversity
Social
Diversity and InclusionPay GapsHealth and SafetyExternalities
Governance
SDG Impact
Financial Data
Business performance

View similiar companies

Company logo
Biomarin Pharmaceutical

United States, Health Care, Biotechnology

Company logo
Exact Sciences

United States, Health Care, Biotechnology

Company logo
Theravance biopharma

United States, Health Care, Biotechnology

Waste generated ⓘTotal waste generated through the company's direct operations, including both hazardous and non-hazardous materials.
37.9tonnes, 2024
Leading
Female employees ⓘProportion of women in the company's total workforce, expressed as a percentage.
52%2024
Aligned
Externalities ⓘThe monetized estimate of environmental and social impacts caused by an organization that are not reflected in its financial accounts.
264.8K$, 2024
Laggard
Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
339.8B$, 2026▼48.1% YoY

Intensity

Energy consumption (direct) intensity (MWh /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark

25.8

B/M 41.5

0.1

B/M 0.4


Powered by illuminem and GIST Impact

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available
Not committed to key sustainability initiatives

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

    Available in
    Scale package

    Access
  • Email
  • Email